Cardiac side effects of chemotherapy: state of art and strategies for a correct management

Item Type:	Article
Title:	Cardiac side effects of chemotherapy: state of art and strategies for a correct management
Creators Name:	Perrino, C. and Schiattarella, G.G. and Magliulo, F. and Ilardi, F. and Carotenuto, G. and Gargiulo, G. and Serino, F. and Ferrone, M. and Scudiero, F. and Carbone, A. and Trimarco, B. and Esposito, G.
Abstract:	In recent years, the development of more effective drugs has provided a better prognosis and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the price for the improving effectiveness of therapies against malignant tumors is the development of severe and potentially life-threatening drug reactions. Among these, cardiac toxic effects have recently gained particular attention. The term cardiotoxicity includes many possible pathological manifestations, but the most frequent is the reduction in cardiac function, potentially leading to heart failure and death. Importantly, the development of cardiac dysfunction may occur immediately after drug administration, or after years. The purpose of this review is to discuss the clinical features of cardiotoxicity, its molecular basis and novel possible strategies to reduce the likelihood of serious cardiac complications.
Keywords:	Anthracyclines, Anti-Neoplastic Drugs, Cancer, Cardiotoxicity, Chemotherapy, Cyclophosphamide, Heart Failure, Fluoropirimidines,, Oxidative Stress, Trastuzumab, Taxanes
Source:	Current Vascular Pharmacology
ISSN:	1570-1611
Publisher:	Bentham
Volume:	12
Number:	1
Page Range:	106-116
Date:	27 March 2014
Official Publication:	https://doi.org/10.2174/157016111201140327163302
PubMed:	View item in PubMed

Repository Staff Only: item control page